Skip to main content

MJFF Publications

4821 - 4830 of 7730 Results
Title
Year
  • Year
  • 2019
  • 2019
  • 2019
  • 2019
  • 2019
  • 2019
  • 2019
  • 2019
  • 2019
  • 2019
  • RESTRICTED
    Title: Efficient RT-QuIC seeding activity for α-synuclein in olfactory mucosa samples of patients with Parkinson’s disease and multiple system atrophy
    Journal Name: Translational Neurodegeneration
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by
    DOI - Digital Object Identifier: 10.1186/s40035-019-0164-x
    Citation Count: 109
  • RESTRICTED
    Title: Cerebrospinal fluid cytokines in multiple system atrophy: A cross-sectional Catalan MSA registry study
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2019.05.040
    Citation Count: 30
  • RESTRICTED
    Title: CONTRIBUTORS
    Journal Name: CONTINUUM: Lifelong Learning in Neurology
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1212/01.con.0000578728.22103.71
    Best OA location URL:
    Citation Count: 0
  • RESTRICTED
    Title: Correlation analysis of [18F]ROStrace using ex vivo autoradiography and dihydroethidium fluorescent imaging in lipopolysaccharide-treated animals
    Journal Name: Biochemical and Biophysical Research Communications
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.bbrc.2019.06.062
    Best OA location URL:
    Citation Count: 6
  • RESTRICTED
    Title: Establishing a framework for neuropathological correlates and glymphatic system functioning in Parkinson’s disease
    Journal Name: Neuroscience & Biobehavioral Reviews
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: elsevier-specific: oa user license
    DOI - Digital Object Identifier: 10.1016/j.neubiorev.2019.05.016
    Citation Count: 95
  • RESTRICTED
    Title: Genetic risk of Parkinson disease and progression:
    Journal Name: Neurology Genetics
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1212/nxg.0000000000000348
    Citation Count: 112
  • RESTRICTED
    Title: L-dopa responsiveness in early Parkinson's disease is associated with the rate of motor progression
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2019.05.022
    Citation Count: 14
  • RESTRICTED
    Title: MAPT p.V363I mutation
    Journal Name: Neurology Genetics
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1212/nxg.0000000000000347
    Citation Count: 11
  • RESTRICTED
    Title: Motor phenotype classification in moderate to advanced PD in BioFIND study
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2019.06.017
    Citation Count: 20
  • RESTRICTED
    Title: Optimized machine learning methods for prediction of cognitive outcome in Parkinson's disease
    Journal Name: Computers in Biology and Medicine
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.compbiomed.2019.103347
    Best OA location URL:
    Citation Count: 39
Filters
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.